The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure

被引:0
|
作者
Tomoyuki Otsuka
Yukinao Sakai
Dai Ohno
Tsuneo Murasawa
Naoki Sato
Shuichi Tsuruoka
机构
[1] Nippon Medical School Musashikosugi Hospital,Division of Nephrology, Department of Internal Medicine
[2] Nippon Medical School Musashikosugi Hospital,Division of Cardiology, Department of Internal Medicine
[3] Graduate School of Medicine,Division of Nephrology, Department of Internal Medicine
[4] Nippon Medical School,undefined
来源
关键词
Tolvaptan; Chronic kidney disease; Diuretic; Congestive heart failure; Renoprotection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:834 / 838
页数:4
相关论文
共 50 条
  • [1] The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure
    Otsuka, Tomoyuki
    Sakai, Yukinao
    Ohno, Dai
    Murasawa, Tsuneo
    Sato, Naoki
    Tsuruoka, Shuichi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (06) : 834 - 838
  • [2] THE EFFECTS OF TOLVAPTON ON SEVERE CHRONIC KIDNEY DISEASE PATIENTS WITH CONGESTIVE HEART FAILURE
    Koibuchi, Kiyoto
    Aoki, Toshiyuki
    Miyagi, Moriatsu
    Sakai, Ken
    Aikawa, Atsushi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 166 - 166
  • [3] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Katsumata, Mari
    Hirawa, Nobuhito
    Sumida, Koichiro
    Kagimoto, Minako
    Ehara, Yosuke
    Okuyama, Yuki
    Fujita, Megumi
    Fujiwara, Akira
    Kobayashi, Mayumi
    Kobayashi, Yusuke
    Yamamoto, Yuichiro
    Saka, Sanae
    Yatsu, Keisuke
    Fujikawa, Tetsuya
    Toya, Yoshiyuki
    Yasuda, Gen
    Tamura, Kouichi
    Umemura, Satoshi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 858 - 865
  • [4] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Mari Katsumata
    Nobuhito Hirawa
    Koichiro Sumida
    Minako Kagimoto
    Yosuke Ehara
    Yuki Okuyama
    Megumi Fujita
    Akira Fujiwara
    Mayumi Kobayashi
    Yusuke Kobayashi
    Yuichiro Yamamoto
    Sanae Saka
    Keisuke Yatsu
    Tetsuya Fujikawa
    Yoshiyuki Toya
    Gen Yasuda
    Kouichi Tamura
    Satoshi Umemura
    [J]. Clinical and Experimental Nephrology, 2017, 21 : 858 - 865
  • [5] Effects of tolvaptan on congestive heart failure complicated with chylothorax in a neonate
    Sato, Nikiko
    Sugiura, Tokio
    Nagasaki, Rika
    Suzuki, Kazutaka
    Ito, Koichi
    Kato, Takenori
    Inukai, Sachiko
    Saitoh, Shinji
    [J]. PEDIATRICS INTERNATIONAL, 2015, 57 (05) : 1020 - 1022
  • [6] Congestive Heart Failure in Patients with Chronic Kidney Disease
    Poskurica, Mileta
    Petrovic, Dejan
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2014, 142 (11-12) : 747 - 755
  • [7] SAFETY OF ADD-ON TOLVAPTAN IN PATIENTS WITH FUROSEMIDE-RESISTANT CONGESTIVE HEART FAILURE COMPLICATED BY ADVANCED-STAGE CHRONIC KIDNEY DISEASE
    Naoto, Tominaga
    Keisuke, Kida
    Naoki, Matsumoto
    Yoshihiro, Akashi J.
    Fumihiko, Miyake
    Kenjiro, Kimura
    Yugo, Shibagaki
    [J]. NEPHROLOGY, 2014, 19 : 164 - 164
  • [8] SHORT-TERM EFFECTS OF TOLVAPTAN ADDED TO FUROSEMIDE IN PATIENTS WITH CONGESTIVE HEART FAILURE AND ADVANCED STAGES OF CHRONIC KIDNEY DISEASE
    Tominaga, Naoto
    Shibagaki, Yugo
    Kida, Keisuke
    Miyake, Fumihiko
    Kimura, Kenjiro
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 137 - 137
  • [9] Aquaporin-2-Guided Tolvaptan Therapy in Patients With Congestive Heart Failure Accompanied by Chronic Kidney Disease
    Imamura, Teruhiko
    [J]. INTERNATIONAL HEART JOURNAL, 2014, 55 (06) : 482 - 483
  • [10] Congestive heart failure in patients with chronic kidney disease and on dialysis
    Schreiber, BD
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 179 - 193